दवाओं की अंतःक्रिया
Baricitinib + Tisagenlecleucel
गंभीरता: गंभीर
Baricitinib and Tisagenlecleucel: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Baricitinib may impair CAR T-cell expansion and activity, possibly reducing efficacy. It also adds to the infection risk that follows lymphodepletion and CAR T therapy.
इस इंटरैक्शन का सरल भाषा में अर्थ
Baricitinib and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Baricitinib belongs to Musculoskeletal; Tisagenlecleucel belongs to Oncology.
ऐसा क्यों होता है
JAK inhibition suppresses T-cell activation and cytokine signaling, adding to immunosuppression and potentially limiting CAR T activity.
क्या करें
Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. Coordinate with the oncology team and monitor for infection.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Baricitinib और Tisagenlecleucel की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Baricitinib के अन्य इंटरैक्शन
- Adenovirus types 4 and 7 live + Baricitinib निषिद्ध
- Baricitinib + Bcg vaccine live निषिद्ध
- Baricitinib + Tofacitinib निषिद्ध
- Baricitinib + Upadacitinib निषिद्ध
- Abatacept + Baricitinib गंभीर
- Adalimumab + Baricitinib गंभीर
Tisagenlecleucel के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Baricitinib with Tisagenlecleucel?
MediHelp rates the interaction as major. Baricitinib and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Baricitinib may impair CAR T-cell expansion and activity, possibly reducing efficacy. It also adds to the infection risk that follows lymphodepletion and CAR T therapy.
How serious is the interaction between Baricitinib and Tisagenlecleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. Coordinate with the oncology team and monitor for infection.
What other medicines interact with Baricitinib?
MediHelp also lists interactions of Baricitinib with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Tofacitinib. The full list is on the Baricitinib page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
